Last reviewed · How we verify
oral mini pulse
The oral mini pulse is a therapeutic regimen developed by Cairo University. It is not an FDA-approved drug but rather a treatment protocol that involves the administration of low doses of corticosteroids over a short period. This approach aims to reduce inflammation and immune system activity, often used in autoimmune and inflammatory conditions. The regimen is tailored to minimize side effects while maintaining efficacy. Due to its non-FDA approved status, detailed safety and efficacy data are limited, and it is primarily used in academic and research settings.
At a glance
| Generic name | oral mini pulse |
|---|---|
| Sponsor | Cairo University |
| Drug class | Corticosteroids |
| Target | Glucocorticoid receptors |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Pipeline indications
Common side effects
Drug interactions
- Anticoagulants
- Diabetes medications
Key clinical trials
- Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination (NA)
- The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo. (PHASE4)
- Oral Mini Pulse Dexamethasone in Pediatric Vitiligo (PHASE4)
- Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers (PHASE1)
- ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation (NA)
- The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo (NA)
- T Central Memory Cells in Early Localized Non-Segmental Vitiligo (NA)
- To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oral mini pulse CI brief — competitive landscape report
- oral mini pulse updates RSS · CI watch RSS
- Cairo University portfolio CI